Login / Signup

A single healthcare experience with Impella RP.

Nikoloz ShekiladzeJose F CondadoPratik B SandesaraJeong Hwan KimChandan DevireddyMichael McDanielVasilis BabaliarosHabib SamadyGautam KumarWissam A Jaber
Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
This study supports the selective use of the Impella RP, with a higher than national reported survival rate (49% vs. 28.6%). Indication appears to be an important factor determining survival.
Keyphrases
  • healthcare
  • extracorporeal membrane oxygenation
  • free survival
  • left ventricular assist device
  • quality improvement